|
Market Closed -
TEL AVIV STOCK EXCHANGE
18:26:59 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,130.00 ILa | -0.09% |
|
-0.70% | +3.29% |
| Market Cap | 129M 0 42.77M 37.29M 35.13M 31.99M 59.98M 4.1B 60.05M 421M 162M 2.09B 161M 157M 6.74B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 257M 0 85.23M 74.31M 69.99M 63.74M 119M 8.16B 120M 838M 323M 4.16B 320M 313M 13.42B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.09% | ||
| 1 week | -0.70% | ||
| Current month | +6.70% | ||
| 1 month | +7.31% | ||
| 3 months | +6.10% | ||
| 6 months | -4.88% | ||
| Current year | +3.29% |
| 1 week | 1,129 |  | 1,139 |
| 1 month | 1,026 | | 1,139 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -0.70% | +1.35% | -36.12% | 42.47M | |
| +1.35% | -2.69% | +27.18% | +102.28% | 102B | |
| +0.16% | -3.89% | +53.08% | +153.37% | 52.42B | |
| -0.78% | -3.80% | -16.23% | +235.10% | 20.85B | |
| +1.19% | -1.23% | -10.26% | -9.86% | 7.88B | |
| +2.53% | +1.90% | -35.75% | -34.02% | 6.83B | |
| +4.09% | -0.27% | -1.56% | +18.39% | 6.41B | |
| +0.60% | -1.63% | -17.84% | -33.29% | 5.97B | |
| +1.10% | -0.54% | -2.48% | +18.79% | 4.94B | |
| -2.92% | +0.71% | +12.05% | +10.49% | 3.79B | |
| Average | +0.76% | -1.43% | +0.95% | +42.51% | 21.11B | |
| Weighted average by Cap. | +0.86% | -1.82% | +22.78% | +109.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 107M 93.02M 87.61M 79.79M 150M 10.22B 150M 1.05B 404M 5.21B 401M 392M 16.8B | 301M 0 99.81M 87.03M 81.97M 74.65M 140M 9.56B 140M 982M 378M 4.87B 375M 367M 15.72B |
| Net income | 6.21M 0 2.06M 1.79M 1.69M 1.54M 2.89M 197M 2.89M 20.24M 7.8M 100M 7.73M 7.56M 324M | -18.07M -0 -5.99M -5.23M -4.92M -4.48M -8.4M -574M -8.41M -58.95M -22.72M -293M -22.51M -22.02M -944M |
| Net Debt | 127M 0 42.14M 36.75M 34.61M 31.52M 59.09M 4.04B 59.17M 414M 160M 2.06B 158M 155M 6.64B | 128M 0 42.45M 37.01M 34.86M 31.75M 59.52M 4.07B 59.6M 417M 161M 2.07B 159M 156M 6.69B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | ILA 1,130.00 | -0.09% | 2,009 |
| 16/09/26 | ILA 1,131.00 | -0.09% | 94 |
| 15/09/26 | ILA 1,132.00 | -0.35% | 639 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
